Editorial
 A CHINESE LESSON FOR INDIA   
 Thursday, February 20, 2020 
 The phrase ‘if China catches cold, India will sneeze’ has become true now, as the outbreak of coronavirus in China is literally sending shivers down the spine of the Indian pharmaceutical industry. 
  Past Editorial...  
TODAY'S NEWS
14:45  [IST]Thyrocare, Datar Cancer Genetics launche blood based cancer screening test for 16 types of cancers
14:30  [IST]Apex court upholds NEET for Ayush under graduate courses
14:15  [IST]C-CAMP and University of Basel team up to spur Indo-Swiss Life Sciences Sister Innovation Hub
14:00  [IST]Palatin Technologies begins phase 2 trial with PL9643 for treatment of dry eye disease
13:45  [IST]Novartis launches digital innovation hub in Hyderabad
13:30  [IST]Tattvan unveils ‘Second medical opinion’ service for multispecialty care patients
more news >>
TOP NEWS
08:00  [IST]DCGI directs drug cos to submit data on 66 FDCs by May 30 based on SC directive
08:00  [IST]Govt extends helping hand to pharma industry to boost API production
08:00  [IST]Bulk drug companies told to pay 0.5% of turnover as corpus fund to restore environment
08:00  [IST]KDPMA stress on creation of database of manufacturers & drugs produced to ensure preparedness to meet epidemics
08:00  [IST]CCI rejects petition against USV and Kundan Pharmacon for resorting to unfair trade practices
08:00  [IST]Rajasthan rolls out red carpet for drug cos by reducing timeline for issuing licenses
more news >>
YESTERDAY'S NEWS
18:00  [IST]NIH study supports new approach for treating cerebral malaria
17:10  [IST]Philips launches vision document at Hospital Design and Build Summit 2020
17:00  [IST]Lockout in parts of China following coronavirus outbreak to affect Indian pharma cos: ICRA
16:20  [IST]Eyestem Research announces successful completion of pre-IND meeting with FDA
16:00  [IST]DNX Biopharmaceuticals enters collaboration with Lung Cancer Initiative at Johnson & Johnson
15:00  [IST]Serum Institute ties up with Codagenix to develop vaccine against corona virus
more news >>
INTERVIEW  
Med-tech ramps up accurate diagnosis with AI and algorithms
120287Ayelet_Interview Dr Ayelet Akselrod-Ballin, director of AI, Zebra Medical Vision
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Chemspex_reg-2020.gif
4th-biowaver_Banner-Ad
Pharma_Manufacturing_150x60_2020
PharmaGM150x60
CPhI_Japan_150x60_2020.jpg
Gulfood_2020
CPhI_China_150x60_CP
BioAsia_2020
pharma_Proj_150x60
Gandhi_auto_2019_Panel
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |